M. Hollander
Molecular Biology · 2011
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 31 citations into it
Whom M. Hollander trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Hollander overall
Papers from M. Hollander's perspective
Ordered by how strongly the researchers M. Hollander trusts endorse each paper. Same corpus, a different order for every researcher.
- P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation (Nature)
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. (Cancer Cell)
- AKT/PKB signaling: navigating downstream. (Cell)
- Essential role for nuclear PTEN in maintaining chromosomal integrity. (Cell)
- Ubiquitination regulates PTEN nuclear import and tumor suppression. (Cell)
- The development of androgen-independent prostate cancer (Nature Reviews. Cancer)
- BRafV600E cooperates with Pten silencing to elicit metastatic melanoma (Nature Genetics)
- The phosphoinositide 3-kinase pathway. (Science)
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
- Pten Dose Dictates Cancer Progression in the Prostate (PLoS Biology)
Their papers
- PTEN loss in the continuum of common cancers, rare syndromes and mouse models (2011) — 805 citations